Creative Planning »

Neurosense Therapeutics shares owned by Creative Planning

Quarter-by-quarter ownership of Neurosense Therapeutics (NRSN) shares owned by Creative Planning from 13F filings

Historical chart of Creative Planning investment in Neurosense Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Neurosense Therapeutics held by Creative Planning consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurosense Therapeutics by Creative Planning

Quarter filed Position value Share count Share price at filing
2025-12-31 $9.2k 12k 0.77

More positions owned by Creative Planning

Ishares Tr Core S&p500 Etf (IVV)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Spdr Series Trust State Street Spd (SPMD)
Ishares Core Msci Emkt (IEMG)
Vanguard Index Fds Large Cap Etf (VV)
Apple (AAPL)
Spdr Series Trust State Street Spd (SPYM)
Vanguard Index Fds Mid Cap Etf (VO)
NVIDIA Corporation (NVDA)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Vanguard Scottsdale Fds Int-term Corp (VCIT)
American Centy Etf Tr Intl Smcp Vlu (AVDV)
Vanguard Bd Index Fds Short Trm Bond (BSV)

View all positions for Creative Planning

Top funds holding Neurosense Therapeutics

Yorkville Advisors Global
Meitav Dash Investments
Gts Securities
UBS Group
Commonwealth Equity Services
Two Sigma Investments
Squarepoint Ops
Pathstone Holdings
Geode Capital Management
Creative Planning
SBI Securities
Jones Financial Companies, L.L
Jessup Wealth Management

View all funds holding Neurosense Therapeutics